Literature DB >> 30546695

Implantation of a MitraClip between two previously implanted MitraClips to treat recurrent severe mitral regurgitation.

Hasema Lesevic1, Carolin Sonne1, Albert Markus Kasel1, Dietmar Breuer2, Adnan Kastrati1,3, Heribert Schunkert1,3, Ilka Ott1.   

Abstract

We first describe the implantation of a MitraClip (Abbott Vascular, Abbott Park, IL, USA) between 2 previously implanted MitraClips to treat recurrent mitral regurgitation (MR). An 82-year-old male patient presented with dyspnea New York Heart Association NYHA class III due to recurrent severe MR 18 months after primarily successful implantation of 2 MitraClips. The initial procedure was performed to treat severe MR due to prolapse and flail of the anterior leaflet and resulted in mild MR after implantation of 2 MitraClips. Concomitant diseases were persistent atrial fibrillation, moderate tricuspid valve regurgitation, and chronic kidney disease stage 3. Thus, the patient was not considered a suitable candidate for surgical treatment. Using fluoroscopic guidance, 2D- and 3D-transesophageal echocardiographies, we succeeded in placing a third clip between the previously implanted clips and reduced the severe MR to mild MR without increase in the mean gradient. No periprocedural complications were observed. Six months after the procedure the patient presented with mild MR and NYHA class I. <Learning objective: Implantation of MitraClips offers the possibility of percutaneous mitral valve repair. It is feasible, safe, and effective to implant a 3rd MitraClip between 2 previously implanted MitraClips to treat recurrent mitral regurgitation between the clips.>.

Entities:  

Keywords:  Interventional repair; Mitral regurgitation; Structural heart disease

Year:  2016        PMID: 30546695      PMCID: PMC6283771          DOI: 10.1016/j.jccase.2016.10.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  7 in total

1.  Percutaneous mitral valve repair for mitral regurgitation: zipping-by-clipping.

Authors:  Robert D Safian
Journal:  Catheter Cardiovasc Interv       Date:  2013-06-01       Impact factor: 2.692

2.  The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation.

Authors:  Laura Mauri; Pallav Garg; Joseph M Massaro; Elyse Foster; Donald Glower; Paul Mehoudar; Ferolyn Powell; Jan Komtebedde; Elizabeth McDermott; Ted Feldman
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

3.  Use of four MitraClip devices in a patient with ischemic cardiomyopathy and mitral regurgitation: "zipping by clipping".

Authors:  Stephan Kische; Christoph Nienaber; Hüseyin Ince
Journal:  Catheter Cardiovasc Interv       Date:  2012-01-10       Impact factor: 2.692

4.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.

Authors:  Francesco Maisano; Olaf Franzen; Stephan Baldus; Ulrich Schäfer; Jörg Hausleiter; Christian Butter; Gian Paolo Ussia; Horst Sievert; Gert Richardt; Julian D Widder; Tiziano Moccetti; Wolfgang Schillinger
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

5.  Multi-MitraClip therapy for severe degenerative mitral regurgitation: "anchor" technique for extremely flail segments.

Authors:  Gagan D Singh; Thomas W Smith; Jason H Rogers
Journal:  Catheter Cardiovasc Interv       Date:  2015-02-12       Impact factor: 2.692

6.  First-in-man report of residual "intra-clip" regurgitation between two MitraClips treated by AMPLATZER Vascular Plug II.

Authors:  Maurizio Taramasso; Michel Zuber; Christiane Gruner; Oliver Gaemperli; Fabian Nietlispach; Francesco Maisano
Journal:  EuroIntervention       Date:  2016-04-20       Impact factor: 6.534

7.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.

Authors:  Ted Feldman; Saibal Kar; Michael Rinaldi; Peter Fail; James Hermiller; Richard Smalling; Patrick L Whitlow; William Gray; Reginald Low; Howard C Herrmann; Scott Lim; Elyse Foster; Donald Glower
Journal:  J Am Coll Cardiol       Date:  2009-08-18       Impact factor: 24.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.